“Right-to-try” laws claim to help terminally patients by allowing them access to experimental drugs before they are approved, when, in fact, their purpose is to undermine and weaken the FDA and such laws strip legal and regulatory protections from patients using such drugs. Now advocates are making a new push to pass right-to-try by embedding it in the very law that funds the FDA. They might succeed if they encounter no opposition from constituents.
Search: “stanislaw burzynski”
We found 410 results for your search.
It’s been a bad week for the Gray Lady in the science department. Hot off the heels of hiring a climate science denier for its op-ed section, it’s published a credulous article that uncritically touts a book full of dubious alternative medicine testimonials.
Share this:
This week, the FDA sent warning letters to 14 companies making unsupported claims that their products can treat cancer. Given the new administration’s determination to deregulate almost everything, but especially the FDA, is this the last time in the foreseeable future that such a crackdown will occur?
Share this:
Ill-advised right-to-try bills are spreading like kudzu through state legislatures. Now federal legislators want to insert right-to-try language into the bill that funds FDA drug approval. Given the support of powerful Republicans for right-to-try, is it too late to stop this juggernaut and protect patients?
Share this:
Orac contemplates a reason why doctors become antivaccine that he missed the last time he discussed this topic.
